BmTI antigens induce a bovine protective immune response against Boophilus microplus tick
dc.contributor.author | Andreotti, R. | |
dc.contributor.author | Gomes, A. | |
dc.contributor.author | Malavazi-Piza, K. C. | |
dc.contributor.author | Sasaki, S. D. | |
dc.contributor.author | Sampaio, CAM | |
dc.contributor.author | Tanaka, A. S. | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.contributor.institution | Empresa Brasileira de Pesquisa Agropecuária (EMBRAPA) | |
dc.date.accessioned | 2016-01-24T12:33:18Z | |
dc.date.available | 2016-01-24T12:33:18Z | |
dc.date.issued | 2002-03-01 | |
dc.description.abstract | Boophilus microplus trypsin inhibitors (BmTIs) present in larvae were preliminarily characterized as active proteins, approximately 10-18 kDa, by SDS-PAGE. BmTIs showed trypsin inhibitory activity on reverse zymography containing gelatin (0.03%) and also inhibited others serine proteinases (human neutrophil elastase and human plasma kallikrein). Bos indicus, Nelore breed calves, previously sensitized with BmTIs and challenged with tick larvae (20,000 larvae/animal), showed 72.8% efficacy to interfere in tick development with 69.7% and 71.3% reduction of both tick number and egg weight, respectively. Cattle BmTIs antiserum titer was approximately 1:8000. the maximum level of BmTIs antibody production was detected 40 days after the first immunization by ELISA. Our preliminary results suggest that B. microplus serine proteinase inhibitors may play a role in the tick larvae fixation and feeding processes. Therefore, the development of antibodies against BmTIs might impair the normal parasitism. (C) 2002 Elsevier Science B.V. All rights reserved. | en |
dc.description.affiliation | UNIFESP, EPM, Dept Bioquim, BR-04044020 São Paulo, Brazil | |
dc.description.affiliation | Embrapa Gado Corte, BR-79002970 Campo Grande, MS, Brazil | |
dc.description.affiliationUnifesp | UNIFESP, EPM, Dept Bioquim, BR-04044020 São Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.format.extent | 557-563 | |
dc.identifier | http://dx.doi.org/10.1016/S1567-5769(01)00203-X | |
dc.identifier.citation | International Immunopharmacology. Amsterdam: Elsevier B.V., v. 2, n. 4, p. 557-563, 2002. | |
dc.identifier.doi | 10.1016/S1567-5769(01)00203-X | |
dc.identifier.issn | 1567-5769 | |
dc.identifier.uri | http://repositorio.unifesp.br/handle/11600/26790 | |
dc.identifier.wos | WOS:000174814500015 | |
dc.language.iso | eng | |
dc.publisher | Elsevier B.V. | |
dc.relation.ispartof | International Immunopharmacology | |
dc.rights | Acesso restrito | |
dc.rights.license | http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy | |
dc.subject | serine proteinase inhibitor | en |
dc.subject | Boophilus microplus | en |
dc.subject | tick | en |
dc.subject | bovine | en |
dc.subject | vaccine | en |
dc.title | BmTI antigens induce a bovine protective immune response against Boophilus microplus tick | en |
dc.type | Artigo |